Last reviewed · How we verify

NCT05802784

Hysteroscopic Septoplasty by Different Modalities

Completed NA Last updated 10 April 2023
What this trial tests

NA trial testing Hysteroscopic septoplasty with scissors in Septate Uterus in 40 participants. Completed in 21 March 2023.

Timeline
16 June 2020
Primary endpoint
1 March 2023
21 March 2023

Quick facts

Lead sponsorMansoura University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date16 June 2020
Primary completion1 March 2023
Estimated completion21 March 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University Hospital

Who can join

Adults 18 to 45, female only, with Septate Uterus or Recurrent Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare in participant population ( women with uterine septum meeting the inclusion criteria) hysteroscopic septoplasty by resectoscope compared to hysteroscopic septoplasty with scissors. The main questions to answer are: Is there a difference in operative time ? Is there a difference in fluid used and fluid deficit? Is there a difference in complications? Is there a difference in reproductive outcome? Researchers will compare the 2 different techniques to see if there is any difference in operative outcome ( operative time, fluid used and deficit, need for second intervention, and operative and postoperative complications) and reproductive outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mansoura University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05802784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing